Inventor
John P. Cooke
Inventor
Palo Alto, CA, US
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C12NMicroorganisms or enzymes12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation6%
C07DHeterocyclic compounds4%
A61LMethods or apparatus for sterilising materials or objects in general3%
C12YEnzymes3%
G02BOptical elements, systems or apparatus2%
PatentTitleYear
10,928,558Optical lens assemblies, head-mounted displays, and related methods202110,928,656Systems and methods for actuation of asymmetric optical elements202110,760,061Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA202010,525,075Compounds, compositions, methods, and kits relating to telomere extension202010,264,974High resolution imaging using near-infrared-II fluorescence201910,238,769Graft for directed vascular and lymphatic regeneration and methods to guide endothelial cell assembly201910,065,046Conductive biopolymer implant for enhancing tissue repair and regeneration using electromagnetic fields20189,738,873'Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA'20179,011,882'Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof'20158,709,735'β-2 microglobulin as a biomarker for peripheral artery disease'20148,377,646'Beta-2 microglobulin as a biomarker for peripheral artery disease'20138,236,772'Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis'20128,227,201'BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease'20128,188,043'Nicotine in therapeutic angiogenesis and vasculogenesis'20128,163,780'Nicotine receptor agonists in stem cell and progenitor cell recruitment'20128,053,204'Beta-2 microglobulin as a biomarker for peripheral artery disease'20118,008,020'Biomarkers for peripheral artery disease'20117,998,743'Panel of biomarkers for peripheral arterial disease'20117,867,719'Beta-2 microglobulin as a biomarker for peripheral artery disease'20117,838,539'Nicotine receptor agonists in stem cell and progenitor cell recruitment'20107,652,038'Methods of reducing angiogenesis'20107,611,844'Methods for detecting asymmetric dimethylarginine in a biological sample'20097,598,275'Nicotine in therapeutic angiogenesis and vasculogenesis'20097,452,916'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity'20087,390,821'Methods of reducing angiogenesis'20087,160,904'Nicotine in therapeutic angiogenesis and vasculogenesis'20077,045,534'Methods of reducing angiogenesis'20066,896,339'Methods and system for controlling latching exhaust valves'20056,720,340'Nicotine receptor agonists in stem cell and progenitor cell recruitment'20046,646,006'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity'20036,642,208'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity'20036,605,115'Method and composition for inhibiting cardiovascular cell proliferation'20036,417,205'Nicotine in therapeutic angiogenesis and vasculogenesis'20026,358,699'Assay for asymmetrical NG, NG dimethyl-l-arginine'20026,337,321'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity'20026,117,872'Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity'20006,063,432'Arginine or lysine containing fruit healthbar formulation'20005,945,452'Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity'19995,891,459'Enhancement of vascular function by modulation of endogenous nitric oxide production or activity'19995,861,168'Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury'19995,852,058'Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury'19985,536,723'S-nitroso derivatives of hydrazinoacetic acids, 1-[(acylthio and (mercapto)-1-oxoalkyl]-1,2,34-Tetrahydroquinoline-2-carboxylic acids and alanyl prolines and isoquinolines'19965,428,070'Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity'19955,356,890'S-nitroso derivatives of ace inhibitors and the use thereof'19945,187,183'S-nitroso derivatives of ACE inhibitors and the use thereof'19935,025,001'S-nitroso derivatives of ACE inhibitors and the use thereof'19914,210,252'Angleworm storage box'1980Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1996Patents assigned to BRIGHAM & WOMENS HOSPITAL (4)· patent assignee history
1991–1996Based in Needham Heights, MA, US· patent location history
1995–2020Patents assigned to UNIV LELAND STANFORD JUNIOR (36)· patent assignee history
1995–2019Based in Palo Alto, CA, US· patent location history
2011–2014Patents assigned to VERMILLION INC (6)· patent assignee history
2012–2018Patents assigned to COOKE JOHN (3)· patent assignee history
2012–2013Patents assigned to COOKE JOHN P (3)· patent assignee history
2017–2020Based in Houston, TX, US· patent location history
2019Based in Stanford, CA, US· patent location history
2021Based in Bothell, WA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV LELAND STANFORD JUNIOR | 36 | 1995–2020 |
| VERMILLION INC | 6 | 2011–2014 |
| BRIGHAM & WOMENS HOSPITAL | 4 | 1991–1996 |
| COOKE JOHNself | 3 | 2012–2018 |
| COOKE JOHN Pself | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Palo Alto, California, US | 35 | 1995–2019 |
| Needham Heights, Massachusetts, US | 4 | 1991–1996 |
| Houston, Texas, US | 3 | 2017–2020 |
| Bothell, Washington, US | 2 | 2021 |
| Stanford, California, US | 1 | 2019 |